Stramsen Biotech Inc. Announced Eleven New Natural Plant-based Drug / Medicine Candidates During its Board Members’ Meeting
Multiple FDA – IND applications are expected to be filed soon. Interested Accredited investors are highly invited. HOUSTON, June 24, 2022 /PRNewswire/ — The Co-Chief Executive Officer of Houston-based Biotechnology Company Stramsen Biotech Inc. Dr. Kefas Mugittu (Ph.D.) has announced…
Comments Off on Stramsen Biotech Inc. Announced Eleven New Natural Plant-based Drug / Medicine Candidates During its Board Members’ Meeting